Should treatment of low-level rifampicin mono-resistant tuberculosis be different?
Gopie FA, Commiesie E, Baldi S, Kamst M, Kaur D, de Lange WCM, Pinas PS, Stijnberg D, Wongsokarijo M, Zijlmans CWR, de Zwaan R, van Soolingen D, Vreden SGS, de Vries G.
Gopie FA, et al. Among authors: vreden sgs.
J Clin Tuberc Other Mycobact Dis. 2021 Jan 29;23:100222. doi: 10.1016/j.jctube.2021.100222. eCollection 2021 May.
J Clin Tuberc Other Mycobact Dis. 2021.
PMID: 33598570
Free PMC article.